SCHEMBL26089257

SCHEMBL26089257

C[C@H]1CN(C2CN(C(=O)O)C2)CCN1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BIRC2 Q13490 1/20 0.41
▸ HRH4 Q9H3N8 1/20 0.34
▸ REN P00797 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26089260 1.00 BIRC2 (0.41) BIRC2HRH4REN
SCHEMBL26090633 0.79 BIRC2 (0.33) BIRC2
SCHEMBL18196176 0.79 BIRC2 (0.36) BIRC2HRH4
SCHEMBL190023 0.79 BIRC2 (0.47) BIRC2HRH4REN
SCHEMBL1181669 0.79 BIRC2 (0.47) BIRC2HRH4REN
SCHEMBL190024 0.79 BIRC2 (0.47) BIRC2HRH4REN
SCHEMBL4541398 0.77 CHRNB2 (0.41) —
SCHEMBL23139621 0.74 BIRC2 (0.34) BIRC2
SCHEMBL25698895 0.74 BIRC2 (0.34) BIRC2
Hydrochloric Acid SCHEMBL25337896 0.72 HPGD (0.34) BIRC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067354-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 — — WO disclosed
Send feedback